UBS has lowered its price target for Givaudan from 4520 to 4380 Swiss francs, but still maintains a "Neutral" rating.
Analyst Charles Eden predicts that Givaudan's operating result (EBITDA) for the second half of the year will be 5 percent higher than consensus estimates.
These adjustments are based on UBS's ongoing evaluation of the market and Givaudan's performance.
Givaudan is scheduled to release its report on January 24, 2024.